$Regenxbio (RGNX.US)$ on 07 Feb will provide an interim clin...
$Regenxbio (RGNX.US)$ on 07 Feb will provide an interim clinical study update of RHX121 for treatment of neuropathic mucopolysaccharaidosis.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more